• 1
    Milam AH, Saari JC, Jacobson SG, Lubinski WP, Feun LG, Alexander KR. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 1993; 34: 91100.
  • 2
    Keltner JL, Thirkill CE, Yip PT. Clinical and immunological characteristics of melanoma-associated retinopathy. J Neuroophthalmol 2001; 21: 17387.
  • 3
    Ladewig G, Reinhold U, Thirkill CE, Kerber A, Tilgen W, Pföhler C. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I–IV. Br J Dermatol 2005; 152: 93138.
  • 4
    Thirkill CE. Cancer-induced, immune-mediated ocular degenerations. Ocul Immunol Inflamm 2005; 13: 11931.
  • 5
    Haus AH, Palmowski AM, Pföhler C, Reinhold U, Gantenbein C, Thirkill CE, Allgayer R, Tilgen W, Ruprecht KW. Melanoma-associated retinopathy: screening for melanoma-associated retinopathy in patients with cutaneous malignant melanoma. J Neuroophthalmol 2002; 27: 12137.
  • 6
    Pföhler C, Haus A, Palmowski A, Ugurel S, Ruprecht KW, Thirkill CE, Tilgen W, Reinhold U. Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma. Br J Dermatol 2003; 149: 748.
  • 7
    Flynn M, Fishman G, Adamus G. Antiretinal Müller cell antibodies in patients with melanoma associated and autoimmune retinopathy. Invest Ophthalmol Vis Sci 2000; 41: 567.
  • 8
    Keltner JL, Thirkill CE. The 22 kDa antigen in optic nerve and retinal diseases. J Neuroophthalmol 1999; 19: 7183.
  • 9
    Potter MJ, Adamus G, Szabo SM, Lee R, Mohaseb K, Behn D. Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Am J Ophthalmol 2002; 134: 12830.
  • 10
    Hartmann TB, Bazhin AV, Schadendorf D, Eichmüller SB. SEREX identification of new tumor antigens linked to melanoma-associated retinopathy. Int J Cancer 2005; 114: 8893.
  • 11
    Sahin U, Tuereci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995; 92: 1181013.
  • 12
    Tureci O, Sahin U, Schobert I, Koslowski M, Schmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG, Pfreundschuh M. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 1996; 56: 476672.
  • 13
    John GB, Shang Y, Ri L, Renken C, Mannella CA, Selker JM, Rangell L, Bennett MJ, Zha J. The mitochondrial inner membrane protein mitofilin controls cristae morphology. Mol Biol Cell 2005; 16: 154354.
  • 14
    Mielenz D, Vettermann C, Hampel M, Lang C, Avramidou A, Karas M, Jack HM. Lipid rafts associate with intracellular B cell receptors and exhibit a B cell stage-specific protein composition. J Immunol 2005; 174: 350817.
  • 15
    Odgren PR, Toukatly G, Bangs PL, Gilmore R, Fey EG. Molecular characterization of mitofilin (HMP), a mitochondria-associated protein with predicted coiled coil and intermembrane space targeting domains. J Cell Sci 1996; 109: 225364.
  • 16
    Gieffers C, Korioth F, Heimann P, Ungermann C, Frey J. Mitofilin is a transmembrane protein of the inner mitochondrial membrane expressed as two isoforms. Exp Cell Res 1997; 232: 3959.
  • 17
    Young TJ, Shah AK, Lee MH, Hayes DL. Kearns-Sayre syndrome: a case report and review of cardiovascular complications. Pacing Clin Electrophysiol 2005; 28: 4547.
  • 18
    Ghadially FN. Ultrastructural pathology of the cell and matrix. Newton, MA: Butterworth-Heinemann, 1997.
  • 19
    Labeit D, Watanabe K, Witt C, Fujita H, Wu Y, Lahmers S, Funck T, Labeit S, Granzier H. Calcium-dependent molecular spring elements in the giant protein titin. Proc Natl Acad Sci USA 2003; 100: 1371621.
  • 20
    Granzier H, Yiming W, Labeit S, LeWinter M. Titin: physiological function and role in cardiomyopathy and failure. Heart Fail Rev 2005; 10: 21123.
  • 21
    Hein S, Scholz D, Fujitani N, Rennollet H, Brand T, Friedl A, Schaper J. Altered expression of titin and contractile proteins in failing human myocardium. J Mol Cell Cardiol 1994; 26: 12911306.
  • 22
    Morano I, Hadicke K, Grom S, Koch A, Schwinger RH, Bohm M, Bartel S, Erdmann E, Krause EG. Titin, moysin light chains and C-protein in the developing and failing human heart. J Mol Cell Cardiol 1994; 26: 3618.
  • 23
    Udd B, Haravuori H, Kalimo H, Partanen J, Pulkkinen L, Paetau A, Peltonen L, Somer H. Tibial muscular dystrophy—from clinical description to linkage on chromosome 2q31. Neuromuscul Disord 1998; 8: 32732.
  • 24
    Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E, Kristensen J, Brandmeier B, Franzen G, Hedberg B, Gunnarsson LG, Hughes SM et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science 2005; 308: 1599603.
  • 25
    Lubke E, Freiburg A, Skeie GO, Kolmerer B, Labeit S, Aarli JA, Gilhus NE, Wollmann R, Wussling M, Ruegg JC, Linke WA. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes. J Neuroimmunol 1998; 81: 98108.
  • 26
    Machado C, Sunkel CE, Andrews DJ. Human autoantibodies reveal titin as a chromosomal protein. J Cell Biol 1998; 141: 32133.
  • 27
    Barron MJ, Johnson MA, Andrews RM, Clarke MP, Griffiths PG, Bristow E, He LP, Durham S, Turnbull GM. Mitochondrial abnormalities in ageing macular photoreceptors. Invest Ophthalmol Vis Sci 2001; 42: 301622.
  • 28
    Tyni T, Paetau A, Strauss AW, Middleton B, Kivela T. Mitochondrial fatty acid β-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacetyl-CoA dehydrogenase deficiency. Pediatr Res 2004; 56: 74450.
  • 29
    Matzinger, P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 9911045.
  • 30
    Jager E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jager D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 1998; 187: 26570.
  • 31
    Neumann F, Wagner C, Kubuschok B, Stevanovic S, Rammensee HG, Pfreundschuh M. Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes. Cancer Immunol Immunother 2004; 53: 58999.
  • 32
    Wagner C, Neumann F, Kubuschok B, Regitz E, Mischo A, Stevanovic S, Friedrich M, Schmidt W, Rammensee HG, Pfreundschuh M. Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2. Cancer Immun 2003; 3: 18.
  • 33
    Neumann F, Wagner C, Preuss KD, Kubuschok B, Schormann C, Stevanovic S, Pfreundschuh M. Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells. Blood 2005; 106: 310513.